Top compounds associated with response to MYO1F

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Sorafenib	GDSC1000	pan-cancer	AAC	0.35	2e-09
mRNA	OSI-930	GDSC1000	pan-cancer	AAC	0.22	2e-08
mRNA	AS605240	GDSC1000	pan-cancer	AAC	0.21	2e-08
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.21	2e-08
mRNA	YM-155	CTRPv2	pan-cancer	AAC	-0.23	3e-08
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.22	4e-08
mRNA	MGCD-265	CTRPv2	pan-cancer	AAC	0.2	5e-08
mRNA	TG-101348	GDSC1000	pan-cancer	AAC	0.17	6e-08
mRNA	PD-0325901	CCLE	pan-cancer	AAC	0.25	6e-08
mRNA	Axitinib	GDSC1000	pan-cancer	AAC	0.22	7e-08

Download CSV